CN205459328U - Increasing of maculopathy of treatment looks appearance - Google Patents
Increasing of maculopathy of treatment looks appearance Download PDFInfo
- Publication number
- CN205459328U CN205459328U CN201521141057.XU CN201521141057U CN205459328U CN 205459328 U CN205459328 U CN 205459328U CN 201521141057 U CN201521141057 U CN 201521141057U CN 205459328 U CN205459328 U CN 205459328U
- Authority
- CN
- China
- Prior art keywords
- maculopathy
- treating
- framework
- vision enhancer
- eye
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000002780 macular degeneration Diseases 0.000 title claims abstract description 29
- 208000035719 Maculopathy Diseases 0.000 title claims abstract description 21
- 230000004438 eyesight Effects 0.000 claims abstract description 24
- 230000003287 optical effect Effects 0.000 claims abstract description 22
- 239000003623 enhancer Substances 0.000 claims description 17
- 238000009434 installation Methods 0.000 claims description 6
- 239000011521 glass Substances 0.000 claims description 4
- 210000004279 orbit Anatomy 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- 230000005611 electricity Effects 0.000 abstract description 2
- 206010064930 age-related macular degeneration Diseases 0.000 description 11
- 208000000260 Warts Diseases 0.000 description 4
- 201000010153 skin papilloma Diseases 0.000 description 4
- 206010025421 Macule Diseases 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000011514 reflex Effects 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020675 Hypermetropia Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 208000022873 Ocular disease Diseases 0.000 description 1
- 208000033240 Progressive symmetric erythrokeratodermia Diseases 0.000 description 1
- 206010038910 Retinitis Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000004418 eye rotation Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000004305 hyperopia Effects 0.000 description 1
- 201000006318 hyperopia Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000000608 photoreceptor cell Anatomy 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
Landscapes
- Radiation-Therapy Devices (AREA)
Abstract
The utility model discloses an increasing of maculopathy of treatment looks appearance indicates especially that one kind is used for improving the optical device of people's eye, belongs to the medical instrument field. An increasing of maculopathy of treatment looks appearance, by the spectacle frame with install that optical devices constitutes on the frame, optical devices include outside image formation device, projector, speculum, sensing and signal transfer device and, wherein outside image formation device and signal transfer device are connected with the projection is electromechanical, and the sensor is connected with signal transfer device electricity. The utility model has the advantages that: easy operation, maculopathy patient's eyesight can effectively be improved to convenient to use, safety.
Description
Technical field
This utility model relates to a kind of vision enhancer treating maculopathy, a kind of for improving human eyesight
Device, belongs to medical instruments field.
Background technology
Senile degeneration of macula (age-relatedmaculardegeneration, AMD) is it is considered to be a class
The different substantiality disease being characterized with the decline of Progressive symmetric erythrokeratodermia central vision and macula area retinitis pigmentasa, is complete
One of primary disease of ball adult's blinding, whole world number of patients 10,000,000, China 60-69 year crowd AMD suffer from
Sick rate is 7.77%, and more than 70 years old up to 15.33%.Annual about 19,000,000 people of China suffer from age-related macular
Degeneration, in the crowd after 65 years old, morbidity steeply rises.Cause a lot of because have of age-related macular degeneration, as lost
Pass, patient self ocular disease and hypermetropia, light color regard, cardiovascular disease etc..
The common trait of age-related macular degeneration is to occur the glass-film wart of yellow under retina, dissipates big patient s pupil
In the case of professional can find it, for glass-film wart, itself be not result in visual deterioration, but
Make glass-film wart become big and time quantity increases when age-related macular degeneration has been in progress, just can cause under serious vision
Fall, the most blind.In addition patients with age-related macular degeneration in late period is in addition to having glass-film wart, also with central retina
The supporting tissue in region and photoreceptor cell，photosensory cell are destroyed, or subretinal exception and fragility blood vessel cause view
Film oozes out or the symptom such as hemorrhage, and this is the basic reason causing visual loss.
In current aging society, the quantity of patients with age-related macular degeneration substantially increases, but so far still without having
Effect slows down or prevents the medicine of age-related macular degeneration progress.Therefore, develop and develop and effectively improve age-related macular
The medical apparatus and instruments of degeneration patient's vision is imperative.
Utility model content
The technical problems to be solved in the utility model is to provide a kind of vision enhancer treating maculopathy.
For achieving the above object, the following design of this utility model employing:
A kind of vision enhancer treating maculopathy, by spectacle framework be arranged on Optical devices on framework and form,
Optical devices include external image formed device, scialyscope, reflecting mirror, sensing and apparatus for transmitting signal and；Its
Peripheral equipment for forming image and apparatus for transmitting signal electrically connect with scialyscope, sensor and apparatus for transmitting signal electricity
Connect.
The installation direction that described external image forms device is consistent with user eye observation direction.
Described external image forms a device image for one scene of formation, and common external image is formed
Device such as minisize pick-up head.
Described scialyscope forms device with external image and coordinates installation, by the outside output signal of beam pattern, throws
Control switch and data processing module it is additionally provided with on shadow machine.
The beam output signal of scialyscope can be reflected in patient's eye by described reflecting mirror.Reflecting mirror is solid by one
Determine device to be located on spectacle framework, make the position of reflecting mirror in the light path of scialyscope output beam, and reflection
After optical axis essentially through the center of rotation of patient's glasses.
Described sensor is for gathering the motor message that patient's eye rotates relative to its eye socket.
Described apparatus for transmitting signal conducts to scialyscope for eye's motor message sensor acquisition arrived,
Thus according to patient's eye in its intra rotation situation, make image beam be exported by scialyscope and be incident upon anti-
Penetrate on a position of mirror, and reflex in patient's eye.
Described spectacle framework preferably employs one-body molded framework；On framework, at least side is provided with eyeglass, and eyeglass can
To be semi-transparent eyeglass, it is also possible to be light tight eyeglass.
Optical devices are located on spectacle framework, are positioned at one side or the front of bilateral eyeglass.The front of framework in
Portion is provided with perforate, forms device for external image and finds a view.
Described Optical devices are powered by external power supply, and framework is additionally provided with power interface.
Being additionally provided with cover body on described spectacle framework, Optical devices are located at inside this cover body, take into account practical and attractive in appearance.
Vision enhancer of the present utility model, is input to, inside vision enhancer, join by external image signal by Optical devices
Close the actuating signal of the patient's eye of sensor input, scialyscope is formed the output signal of beam pattern, should
Light beam reflects through reflecting mirror, and optical axis is essentially through the center of rotation of patient's glasses, in patient's maculopathy district
Territory is treated.This use new device is possible not only to improve the vision suffering from AMD eyes, it may also be used for many
Industry, dual-use application.
The utility model has the advantages that: simple to operate, easy to use, safe, maculopathy can be effectively improved and suffer from
The vision of person.
Describe the technical solution of the utility model in detail below by way of the drawings and specific embodiments, do not limit with this
Fixed practical range of the present utility model, all this area equivalents carried out according to this utility model disclosure content,
Belong to protection domain of the present utility model.
Accompanying drawing explanation
Fig. 1 is external structure schematic diagram of the present utility model
Fig. 2 is Optical devices annexation schematic diagram of the present utility model
Detailed description of the invention
Embodiment 1
Shown in seeing figures.1.and.2, a kind of vision enhancer treating maculopathy, by spectacle framework 1 and installation
On framework Optical devices composition, Optical devices include external image formed device 2, scialyscope 3, reflecting mirror 4,
Sensor 5 and apparatus for transmitting signal 6；Wherein external image forms device 2 and apparatus for transmitting signal 6 and scialyscope
3 electrical connections, sensor 5 electrically connects with apparatus for transmitting signal 6.
Spectacle framework 1 is formed in one framework；Eyeglass 13 is light tight eyeglass, and framework is provided with cover body 12.
Optical devices are positioned at cover body 12, the front of unilateral eyeglass 13.The front of framework is provided with perforate 15 at middle part,
Form device 2 for external image to find a view.
Scialyscope 3 forms device 2 with external image and coordinates installation, by the outside output signal of beam pattern, throws
Shadow machine 3 is provided with control input switch.Reflecting mirror 4 is fixed on spectacle framework, the optical axis base of reflecting mirror 4
Through the center of rotation of patient's glasses in basis, and the position of reflecting mirror 4 is in the light path of scialyscope output beam；
The beam output signal of scialyscope 3 is reflected in patient's eye 7 by reflecting mirror 4.Sensor 5 and signal transmission dress
Put 6 electrical connections；Sensor 5 gathers the signal that patient's eye rotates, apparatus for transmitting signal 6 relative to its eye socket
The signal collected by sensor 5 conducts to scialyscope 3.The data processing module of scialyscope 3 is according to patient's eye
Rotation situation processes, and final image light beam is exported and is incident upon a position of reflecting mirror 4 by scialyscope 3
Put, reflex in patient's eye 7.
Optical devices are powered by external power supply, and spectacle framework 1 is provided with power interface 14.
Claims (10)
1. treat a vision enhancer for maculopathy, by spectacle framework be arranged on Optical devices on framework and form,
It is characterized in that: Optical devices include that external image forms device, scialyscope, reflecting mirror, sensing and signal and passes
Delivery device and；Wherein external image forms device and apparatus for transmitting signal electrically connects with scialyscope, sensor and letter
The electrical connection of number transfer device.
A kind of vision enhancer treating maculopathy the most according to claim 1, it is characterised in that: outside described
The installation direction of portion's equipment for forming image is consistent with user eye observation direction.
A kind of vision enhancer treating maculopathy the most according to claim 1, it is characterised in that: outside described
Portion's equipment for forming image is for forming an image of a scene.
A kind of vision enhancer treating maculopathy the most according to claim 1, it is characterised in that: described throwing
Shadow machine forms device with external image and coordinates installation, by the outside output signal of beam pattern, scialyscope also sets
There are control switch and data processing module.
A kind of vision enhancer treating maculopathy the most according to claim 1, it is characterised in that: described instead
Penetrate mirror to be located on spectacle framework by a fixing device, make the position of reflecting mirror at scialyscope output beam
In light path, and the optical axis after reflection is essentially through the center of rotation of patient's glasses.
A kind of vision enhancer treating maculopathy the most according to claim 1, it is characterised in that: described biography
Sensor is for gathering the motor message that patient's eye rotates relative to its eye socket.
A kind of vision enhancer treating maculopathy the most according to claim 1, it is characterised in that: described eye
Mirror framework uses one-body molded framework.
A kind of vision enhancer treating maculopathy the most according to claim 1, it is characterised in that: described eye
Being additionally provided with cover body on mirror framework, Optical devices are located at inside this cover body.
A kind of vision enhancer treating maculopathy the most according to claim 1, it is characterised in that: described eye
The front of mirror framework is provided with perforate at middle part.
A kind of vision enhancer treating maculopathy the most according to claim 1, it is characterised in that: described
Optical devices are powered by external power supply, and spectacle framework is provided with power interface.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201521141057.XU CN205459328U (en) | 2015-12-30 | 2015-12-30 | Increasing of maculopathy of treatment looks appearance |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201521141057.XU CN205459328U (en) | 2015-12-30 | 2015-12-30 | Increasing of maculopathy of treatment looks appearance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN205459328U true CN205459328U (en) | 2016-08-17 |
Family
ID=56663372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201521141057.XU Expired - Fee Related CN205459328U (en) | 2015-12-30 | 2015-12-30 | Increasing of maculopathy of treatment looks appearance |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN205459328U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114344726A (en) * | 2021-12-10 | 2022-04-15 | 复旦大学附属眼耳鼻喉科医院 | Programmable figure projection light source system for ophthalmology |
-
2015
- 2015-12-30 CN CN201521141057.XU patent/CN205459328U/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114344726A (en) * | 2021-12-10 | 2022-04-15 | 复旦大学附属眼耳鼻喉科医院 | Programmable figure projection light source system for ophthalmology |
| CN114344726B (en) * | 2021-12-10 | 2022-10-11 | 复旦大学附属眼耳鼻喉科医院 | Ophthalmic graphic projection light source system able to programme |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI705280B (en) | Pulsed plus lens designs for myopia control, enhanced depth of focus and presbyopia correction | |
| KR102564748B1 (en) | Methods and system for diagnosing and treating health ailments | |
| TWI599812B (en) | Neuromuscular sensing for variable-optic electronic ophthalmic lens | |
| KR20170047172A (en) | Electronic ophthalmic lens with alarm clock | |
| TW201545713A (en) | Vision Protection Method and System Thereof | |
| CN101806960B (en) | Blue light resistant tawny polarized sunglasses lens | |
| CN104382729A (en) | Vision correction training system and method | |
| CN205459328U (en) | Increasing of maculopathy of treatment looks appearance | |
| CN203705735U (en) | Humidifying-space glasses | |
| CN208525213U (en) | A kind of ophthalmic cornea oxygen blast eyeshade | |
| CN106963547A (en) | The intelligent eye-cover for weak sight of monitoring in real time | |
| CN204269941U (en) | A kind of adjustable paracentral fixation glasses | |
| CN110269789A (en) | A kind of fixed Eyeball training device and training method | |
| CN206167324U (en) | Physiotherapy glasses of prevention myopia stravismus | |
| Takhchidi et al. | A bionic eye: performance of the Argus II retinal prosthesis in low-vision and social rehabilitation of patients with end-stage retinitis pigmentosa | |
| CN212016134U (en) | Eye muscle training glasses | |
| CN205539783U (en) | Adopt spallation crack of going of crack lens preparation to make up mirror | |
| US20100134757A1 (en) | Optical rehabilitation treatment | |
| CN102830506A (en) | Multiple-efficacy eye disease protection eyeglass and finished eyeglasses assembled by same | |
| Werblin et al. | Restoring vision to the blind: advancements in vision aids for the visually impaired | |
| RU2196497C2 (en) | Device for diagnosing vision system pathologies in children based on critical frequency of flicker fusion | |
| CN108937840A (en) | A kind of amblyopia in children strabismus diagnosis orthotic device and its correcting method | |
| Bjorklund | The Senses | |
| Baritz et al. | Study of pupil reflex under chromatic light radiation incidence | |
| CN209662146U (en) | A kind of astigmatism correction therapeutic device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20160826 Address after: 030021 Shanxi Province, Taiyuan city Jinyuan District South Jinci Road No. 579 fruit trees Patentee after: SHANXI RUIHAO BIOTECHNOLOGY CO.,LTD. Address before: 300457 Tianjin international biological medicine Joint Research Institute, Tianjin 220, Dongting Road, economic and Technological Development Zone, Binhai New Area, S606-2 Patentee before: Tianjin Ruishi Blue Light Technology Co.,Ltd. |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20190104 Address after: 300 457 days S606-2, Tianjin Joint Research Institute of Biomedicine, 220 Dongting Road, Tianjin Economic and Technological Development Zone Patentee after: Tianjin Ruishi Blue Light Technology Co.,Ltd. Address before: 030021 No. 579 Nanjin Temple Road, Guoshuchang, Jinyuan District, Taiyuan City, Shanxi Province Patentee before: SHANXI RUIHAO BIOTECHNOLOGY CO.,LTD. |
|
| TR01 | Transfer of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160817 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |